Journal ArticleOPEN ACCESS

Diazoxide for Lowering Insulin Levels in Breast Cancer Patients

  • Fink M
  • Klement R
The Oncologist (2017) 22(4) 491-491
DOI: 10.1634/theoncologist.2016-0402
2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diazoxide is a nondiuretic benzothiadiazine that produces hyperglycemia by lowering insulin levels through activation of ATP-sensitive K1-channels and stimulating insulin degradation in the lysosomal system. Its effect on cancer growth is discussed.

Cite

CITATION STYLE

APA

Fink, M. K., & Klement, R. J. (2017). Diazoxide for Lowering Insulin Levels in Breast Cancer Patients. The Oncologist, 22(4), 491–491. https://doi.org/10.1634/theoncologist.2016-0402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free